tiprankstipranks
Advertisement
Advertisement
iRhythm price target lowered to $180 from $225 at BofA
PremiumThe FlyiRhythm price target lowered to $180 from $225 at BofA
18d ago
MACs’ revised policy positive for iRhythm, says BTIG
Premium
The Fly
MACs’ revised policy positive for iRhythm, says BTIG
29d ago
PANDA Trial Completion Puts iRhythm’s Pediatric Growth Story in Focus
Premium
Company Announcements
PANDA Trial Completion Puts iRhythm’s Pediatric Growth Story in Focus
29d ago
iRhythm price target raised to $175 from $166 at Baird
PremiumThe FlyiRhythm price target raised to $175 from $166 at Baird
1M ago
iRhythm price target lowered to $175 from $215 at JPMorgan
Premium
The Fly
iRhythm price target lowered to $175 from $215 at JPMorgan
1M ago
iRhythm price target lowered to $185 from $225 at Oppenheimer
Premium
The Fly
iRhythm price target lowered to $185 from $225 at Oppenheimer
1M ago
iRhythm reports Q1 adjusted EPS (35c), consensus (64c)
PremiumThe FlyiRhythm reports Q1 adjusted EPS (35c), consensus (64c)
1M ago
iRhythm sees FY26 revenue $875M-$885M, consensus $876.16M
Premium
The Fly
iRhythm sees FY26 revenue $875M-$885M, consensus $876.16M
1M ago
2 Under-the-Radar Wearable AI Stocks Analysts Are Bullish On
Premium
Stock Analysis & Ideas
2 Under-the-Radar Wearable AI Stocks Analysts Are Bullish On
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100